Skip to main content
Log in

Safety and effectiveness in explantation and re-implantation of hypoglossal nerve stimulation devices

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

Since 2001, hypoglossal nerve stimulators have been implanted in patients with obstructive sleep apnea around the world, initially in trial situations but more recently also in regular care settings. Medium term data indicate effectiveness and tolerability of treatment. However, when assessing the safety of the procedure, the safe feasibility of explantation or reimplantation must also be considered.

Patients and methods

Nine patients with an implanted respiratory-driven hypoglossal nerve stimulator. We have evaluated the feasibility and safety of explantation or re-implantation with another stimulation system.

Results

In 2012, nine patients were implanted with a respiratory-driven hypoglossal nerve stimulator as part of the Apnex Medical Pivotal Study. The study was ended in 2013. For a variety of reasons, the system was explanted from all nine patients by the year 2019. Three of these patients were re-implanted with a different system with respiratory sensing during the same session (mean incision to closure time for explantation 88.2 ± 35.01 min., mean incision to closure time for re-implantation 221.75 ± 52.73 min.). Due to extensive scar tissue formation, all procedures were technically challenging. Complication rate was significantly higher when re-implantation was performed or attempted in the same surgical session (0 of 5 patients with explantation versus 3 of 4 patients with attempted re-implantation; p = 0.018). There was no significant difference between the AHI values before and after implantation in patients with re-implantation.

Conclusion

Explantation and re-implantation are technically challenging though possible procedures. The single-staged equilateral reimplantation of another hypoglossal nerve stimulation system can, but need not, be successful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and material (data transparency)

All data and materials support the published claims and comply with field standards.

References

  1. Zaidi FN, Meadows P, Jacobowitz O, Davidson TM (2012) Tongue anatomy and physiology, the scientific basis for a novel targeted neurostimulation system designed for the treatment of obstructive sleep apnea. Neuromodulation. https://doi.org/10.1111/j.1525-1403.2012.00514.x

    Article  PubMed  Google Scholar 

  2. Dedhia RC, Strollo PJ, Soose RJ, Soose RJ (2015) Upper airway stimulation for obstructive sleep apnea: past, present, and future. Sleep 38:899–906. https://doi.org/10.5665/sleep.4736

    Article  PubMed  PubMed Central  Google Scholar 

  3. Certal VF, Zaghi S, Riaz M et al (2015) Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: a systematic review and meta-analysis. Laryngoscope 125:1254–1264. https://doi.org/10.1002/lary.25032

    Article  PubMed  Google Scholar 

  4. Eastwood PR, Barnes M, MacKay SG et al (2019) Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnea. Eur Respir J. https://doi.org/10.1183/13993003.01320-2019

    Article  Google Scholar 

  5. Schwartz AR, Bennett ML, Smith PL et al (2001) Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Neck Surg 127:1216. https://doi.org/10.1001/archotol.127.10.1216

    Article  CAS  Google Scholar 

  6. Smith PL, Eisele DW, Podszus T et al (1996) Electrical stimulation of upper airway musculature. Sleep 19:S284–S287

    CAS  PubMed  Google Scholar 

  7. Eisele DW, Smith PL, Alam DS, Schwartz AR (1997) Direct hypoglossal nerve stimulation in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 123:57–61

    Article  CAS  Google Scholar 

  8. Boon M, Huntley C, Steffen A et al (2018) Upper airway stimulation for obstructive sleep apnea: results from the ADHERE Registry. Otolaryngol Neck Surg 159:379–385. https://doi.org/10.1177/0194599818764896

    Article  Google Scholar 

  9. Steffen A, Sommer JU, Hofauer B et al (2018) Outcome after one year of upper airway stimulation for obstructive sleep apnea in a multicenter German post-market study. Laryngoscope 128:509–515. https://doi.org/10.1002/lary.26688

    Article  PubMed  Google Scholar 

  10. Strollo PJ, Soose RJ, Maurer JT et al (2014) Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 370:139–149. https://doi.org/10.1056/NEJMoa1308659

    Article  CAS  PubMed  Google Scholar 

  11. Schwartz AR, Barnes M, Hillman D et al (2012) Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med 185:420–426. https://doi.org/10.1164/rccm.201109-1614OC

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kezirian EJ, Goding GS, Malhotra A et al (2014) Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes. J Sleep Res 23:77–83. https://doi.org/10.1111/jsr.12079

    Article  PubMed  Google Scholar 

  13. Eastwood PR, Barnes M, Walsh JH et al (2011) Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep 34:1479–1486. https://doi.org/10.5665/sleep.1380

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mwenge GB, Rombaux P, Dury M et al (2012) Targeted hypoglossal neurostimulation for obstructive sleep apnoea. A 1 year pilot Study. Eur Respir J Off J Eur Soc Clin Respir Physiol. https://doi.org/10.1183/09031936.00042412

    Article  Google Scholar 

  15. Friedman M, Jacobowitz O, Hwang MS et al (2016) Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: six-month results. Laryngoscope. https://doi.org/10.1002/lary.25909

    Article  PubMed  Google Scholar 

  16. Strollo PJ, Gillespie MB, Soose RJ et al (2015) Upper airway stimulation for obstructive sleep apnea: durability of the treatment effect at 18 months. Sleep 38:1593–1598. https://doi.org/10.5665/sleep.5054

    Article  PubMed  PubMed Central  Google Scholar 

  17. Woodson BT, Strohl KP, Soose RJ et al (2018) Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Neck Surg 159:194–202. https://doi.org/10.1177/0194599818762383

    Article  Google Scholar 

  18. Gillespie MB, Soose RJ, Woodson BT et al (2017) Upper airway stimulation for obstructive sleep apnea: patient-reported outcomes after 48 months of follow-up. Otolaryngol Neck Surg 156:765–771. https://doi.org/10.1177/0194599817691491

    Article  Google Scholar 

  19. Thaler E, Schwab R, Maurer J et al (2019) Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscopelary. https://doi.org/10.1002/lary.28286

    Article  Google Scholar 

  20. Ughratdar I, Kawsar KA, Mitchell R et al (2018) Use of pulsed radiofrequency energy device (PEAK plasmablade) in neuromodulation implant revisions. World Neurosurg 112:31–36. https://doi.org/10.1016/J.WNEU.2018.01.007

    Article  PubMed  Google Scholar 

Download references

Funding

Apnex Medical Pivotal Study was financed by Apnex Medical Inc. Aftercare and evaluation of patient data in clinical follow-up—as presented here—was not financed.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by PA, SD, IF, AB and BW. Supervision was done by TP. The first draft of the manuscript was written by PA. Reviewing and editing of the manuscript was done by SD, TP and HO. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Philipp Arens.

Ethics declarations

Conflict of interest

Philipp Arens P, Thomas Penzel, Ingo Fietze, Alexander Blau, Heidi Olze and Steffen Dommerich received financial support from ImThera Inc. and Apnex Medical Inc. within the framework of research projects related to hypoglossal nerve stimulation therapy. Philipp Arens received a speaker’s fee for an invited talk on behalf of Inspire Medical Inc.

Ethical approval

Procedures performed within the Apnex Pivotal Study were in accordance with the ethical standards of the national research committee (LAGeSo Berlin, 11/0326-ZS EK 11) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Informed consent was obtained from all individual participants included in the study.

Code availability (software application or custom code)

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arens, P., Penzel, T., Fietze, I. et al. Safety and effectiveness in explantation and re-implantation of hypoglossal nerve stimulation devices. Eur Arch Otorhinolaryngol 278, 477–483 (2021). https://doi.org/10.1007/s00405-020-06170-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-020-06170-w

Keywords

Navigation